CSIMarket
 
Avalon Globocare Corp  (NASDAQ: ALBT)
 
Price: $0.2184 $0.22 %
Day's High: $0.23389999568462372 Week Perf: -19.35 %
Day's Low: $ 0.21 30 Day Perf: -22.55 %
Volume (M): 268,373 52 Wk High: $ 2.90
Volume (M$): $ 0 52 Wk Avg: $1.08
Open: $0.22 52 Wk Low: $0.21



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 16
 Employees 2
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Business Description


Avalon Globocare Corp is a biotechnology company that primarily focuses on developing and commercializing innovative cell-based technologies and therapeutics. The company operates in the United States and China and has a wide range of healthcare and wellness products in its portfolio. Avalon Globocare Corp aims to transform the field of healthcare by using cutting-edge technologies such as gene therapy, cellular immunotherapy, and regenerative medicine. Their goal is to provide advanced and personalized treatment options to patients, ultimately improving their quality of life.


   Company Address: 4400 Route 9 South Freehold 7728 NJ
   Company Phone Number: 780-4400   Stock Exchange / Ticker: NASDAQ ALBT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CRIS   -11.64%    
SNTI   -6.68%    
• View Complete Report
   



Product Service News

Avalon GloboCare Expands Market Reach with Launch of Innovative KetoAir Breathalyzer and Affiliate Program in the UK

Published Fri, Aug 29 2025 6:22 PM UTC

Avalon GloboCare: Innovating Health Monitoring with the KetoAir Breathalyzer and Expanding Affiliate Opportunities In a significant stride toward enhancing health monitoring solutions, Avalon GloboCare Corp. (NASDAQ: ALBT), a pioneer in precision diagnostic consumer products, announced the upcoming launch of its groundbreaking KetoAir breathalyzer in the United Kingdom. This...

Partnership

Health on the Beat Avalon GloboCare Partners with SpecialtyHealth to Supercharge Police Chiefs Fitness Challenge with...

Published Tue, Apr 15 2025 1:00 PM UTC

Avalon GloboCare Partners with SpecialtyHealth, Inc. to Enhance Police Chiefs Fitness Challenge with Innovative KetoAir Breathalyzer Technology In a pioneering initiative aimed at supporting law enforcement s health and fitness, Avalon GloboCare has announced a strategic partnership with SpecialtyHealth, Inc. to integrate its advanced KetoAir breathalyzer technology into the...

Merger and Acquisition

YOOV Reports Impressive Revenue Surge with 59.1% Growth for 2024, Amidst Strategic Changes at Avalon Globocare

Published Mon, Mar 10 2025 12:01 PM UTC

Breaking News: YOOV Achieves 59.1% Annual Revenue Growth, Reporting Unaudited Revenue of $45.7 Million with Net Income of $3.4 Million for Calendar Year 2024In a remarkable turnaround, YOOV has announced unaudited financial results for the calendar year 2024, achieving an impressive 59.1% increase in annual revenue. The biotechnology and pharmaceuticals company reported a re...

Stock Market Announcement

Avalon GloboCare Regains Compliance with Nasdaq Requirements Following Strategic Reverse Stock Split

Published Thu, Nov 21 2024 2:01 PM UTC

Avalon GloboCare Corp. (NASDAQ: ALBT), a Freehold, New Jersey-based innovator in precision diagnostics and laboratory services, has received significant positive news from the Nasdaq Stock Market. On November 19, 2024, the company was notified that it has regained compliance with Nasdaq s minimum bid price requirement, as outlined in Rule 5550(a)(2). This development marks a...

Product Service News

Avalon GloboCare Launches Innovative Affiliate Program for AI-Enabled KetoAir Breathalyzer,

Published Mon, Nov 18 2024 2:00 PM UTC

FREEHOLD, N.J. Avalon GloboCare Corp. (NASDAQ: ALBT), a leader in precision diagnostics and laboratory services, has officially rolled out its innovative BrAce for Impact affiliate marketing program to promote its latest product, the KetoAir breathalyzer device. This handheld breathalyzer is equipped with advanced AI-enabled software and Hot App shareable technology speci...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 0.34
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.27
Working Capital Ratio 0.36
Leverage Ratio (MRQ) 0.48
Total Debt to Equity 0.14
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.39 $
Revenues (TTM) -
Cash Flow (TTM) 0.05 $
Cash 0.08 $
Book Value 0.64 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -4,489,387
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.